COVID-19: what has been learned and to be learned about the novel coronavirus diseaseReview Published on 2020-03-152022-10-29 Journal: International Journal of Biological Sciences [Category] COVID-19, MERS, SARS, [키워드] acute respiratory syndrome Affect bat cause caused China coronavirus Coronavirus disease 2019 COVID-19 Diagnosis disease emerging disease Epidemiology etiology help homologous humans individual mechanism men Mortality novel coronavirus disease outbreak Pneumonia Prognosis question Research resulting SARS-CoV SARS-CoV-2 severity subject Symptom the disease transmitted Treatment virus women [DOI] 10.7150/ijbs.45134 PMC 바로가기 [Article Type] Review
Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severityLetter Published on 2020-02-262022-10-31 Journal: Emerging Microbes & Infections [Category] COVID-19, MERS, SARS, [키워드] 2019-nCoV anal swab analyzed Blood blood viral RNA caused Clinical severity Cohort Concentration correlation detectable digestive tract Infection lab Laboratory test Novel coronavirus Patient patients Pharyngeal swab Pneumonia progressed Real-time PCR replicate RNA serum severity Swab Symptom the disease Viral RNA virus virus RNA [DOI] 10.1080/22221751.2020.1732837 PMC 바로가기 [Article Type] Letter
Overnutrition in Infants Is Associated With High Level of Leptin, Viral Coinfection and Increased Severity of Respiratory Infections: A Cross-Sectional StudyOriginal Research Published on 2020-02-182023-08-30 Journal: Frontiers in Pediatrics [Category] E형 간염, [키워드] children Leptin overnutrition severity viral coinfection viral respiratory infection [DOI] 10.3389/fped.2020.00044 PMC 바로가기 [Article Type] Original Research
Estimation of the Transmission Risk of the 2019-nCoV and Its Implication for Public Health InterventionsArticle Published on 2020-02-072022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] 2019-nCoV 2019-nCoV infection 95% CI adopted Analysis baseline value basic reproduction number Beijing Chinese compartmental model Contact tracing contribute coronavirus Critical decrease disease epidemiological estimation expected individual individuals Infection infection management and control information intensity Intensive Intervention Isolation likelihood mathematical mathematical model measure Measures Novel coronavirus number of infected outbreak progression Public quarantine reduce Reproduction number risk SEIR model Seven severity the disease Transmission Travel Travel restriction Wuhan Wuhan, China [DOI] 10.3390/jcm9020462 PMC 바로가기 [Article Type] Article
Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020Rapid Communication Published on 2020-01-232022-10-31 Journal: Eurosurveillance [Category] COVID-19, Fulltext, MERS, [키워드] 2019-nCoV acute respiratory disease Characteristics coronavirus epidemiological fatality hospitalised human-to-human transmission increasingly indicate information mild case Novel coronavirus Novel coronavirus infection public health reported risk severity Spread sustained while Wuhan, China [DOI] 10.2807/1560-7917.ES.2020.25.3.2000044 PMC 바로가기 [Article Type] Rapid Communication
Variants in ACE2 and TMPRSS2 Genes Are Not Major Determinants of COVID-19 Severity in UK Biobank SubjectsACE2 및 TMPRSS2 유전자의 변이는 영국 바이오뱅크 피험자에서 COVID-19 심각도의 주요 결정 요인이 아닙니다Article Published on 2020-01-012022-09-11 Journal: Human heredity [Category] SARS, 변종, [키워드] ACE2 affecting Analysis carried conducted contribute Control controls COVID-19 COVID-19 severity determinant determine develop DNA sequence Effect effect sizes explain Frequency genetic variants infection with SARS-CoV-2 Major positive rare variant Rare variants Research SARS-CoV-2 sequence sequenced severe disease severe symptom severe symptoms severity statistically significant difference subject subjects tested TMPRSS2 TMPRSS2 protein UK biobank variant variants Variation was obtained [DOI] 10.1159/000515200 PMC 바로가기 [Article Type] Article
Use of a Humanized Anti-CD6 Monoclonal Antibody (Itolizumab) in Elderly Patients with Moderate COVID-19중등도의 COVID-19가 있는 고령 환자에서 인간화 항-CD6 단클론항체(이톨리주맙)의 사용Clinical Trial Published on 2020-01-012022-09-12 Journal: Gerontology [Category] SARS, 임상, 진단, [키워드] acute respiratory syndrome age antibody Antiviral baseline caused circulating Clinical outcome clinical trial clinically Combination Comorbidities Complication Concentration control group control subject coronavirus coronavirus disease Course COVID-19 COVID-19 disease COVID-19 patient Cuba Cytokine release syndrome discharged dose elderly first dose humanized IL-6 ill patient immunomodulatory drugs immunomodulatory therapy individual intensive care itolizumab Local Medical conditions monoclonal antibody Mortality multiple comorbidity outbreak Pathologies Patient patients with COVID-19 polymerase chain positive receive reduce reduced remained reported reverse transcription risk of death SARS-CoV-2 SARS-COV-2 infection severity susceptibility susceptible tested the disease therapeutic took place Transmission treated Treatment Villa was selected worsening [DOI] 10.1159/000512210 PMC 바로가기 [Article Type] Clinical Trial
Approaches for the Treatment of SARS-CoV-2 Infection: A Pharmacologic View and Literature ReviewReview Article Published on 2020-01-012022-10-30 Journal: Iranian Journal of Pharmaceutical Research : IJPR [Category] COVID-19, [키워드] acute respiratory distress acute respiratory distress syndrome (ARDS) approach ARDS caused China clinical manifestations clinical trial coronavirus coronavirus 2 Coronavirus disease 2019 COVID-19 COVID-19 disease disease drugs targeting effective effective drug effort elements host cell identify knowledge literature medication Mild moderate new virus offered outcomes pandemic Pharmacologic potential therapy public health Quickly respiratory review SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 virus severity Spread Stage suggested syndrome the disease therapy Treatment View virus [DOI] 10.22037/ijpr.2020.113821.14506 PMC 바로가기 [Article Type] Review Article
Diabetes Mellitus, Hypertension, and Death among 32 Patients with MERS-CoV Infection, Saudi ArabiaResearch Letter Published on 2020-01-012022-10-31 Journal: Emerging Infectious Diseases [Category] Coronavirus, MERS, [키워드] clinical outcomes death Diabetes Mellitus Frequency hypertension Infection MERS-CoV Middle East Middle East respiratory syndrome Coronavirus Patient respiratory syndrome coronavirus risk factor Saudi Arabia severity underlying conditions vector-borne infections viruses zoonoses [DOI] 10.3201/eid2601.190952 PMC 바로가기 [Article Type] Research Letter
Rationale and design of the “Tocilizumab in patients with moderate to severe COVID-19: an open-label multicentre randomized controlled” trial (TOCIBRAS)"중등도에서 중증의 COVID-19 환자에 대한 토실리주맙: 공개 라벨 다기관 무작위 통제" 시험(TOCIBRAS)의 근거 및 설계Original Article Published on 2020-01-012022-08-13 Journal: Revista Brasileira de Terapia Intensiva [Category] 임상, [키워드] 7-point ordinal scale adjusted age and sex alleviate Analysis anti-inflammatory therapies Anti-inflammatory therapy applied approved Brazil C reactive protein Clinical outcome clinical outcomes clinical status combating consequence Coronavírus COVID-19 COVID-19 patient COVID-19 patients criteria D-dimer disease severity dissemination enrolment ethical committee Ethics ferritin IMPROVE inflammatory cascade inflammatory mediator Inflammatory response inhibiting institutional review board institutional review boards interleukin-6 International Lactate lactate dehydrogenase limit Local mediator moderate to severe multicentre National Odds ratio Open-label ordinal logistic regression Ordinal Scale outcome patients patients with COVID-19 patients with moderate primary endpoint Pro-inflammatory marker pro-inflammatory markers protocol Randomized Randomized controlled trial rationale required severe COVID-19 severity Standard of care Stratification Study protocol the disease The TOCIBRAS protocol TOCIBRAS Tocilizumab Tocilizumabe Trial trial testing variable [DOI] 10.5935/0103-507X.20200060 PMC 바로가기 [Article Type] Original Article